• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Torrent Pharmaceuticals Ltd.
    03 Jul 2024
    3583.60
    -0.23%
    Torrent Pharma - Focus On Branded Generics, Profitability: HDFC Securities
    Torrent Pharma - Focus On Branded Generics, Profitability: HDFC Securities
    NDTV Profit
    Its two plants Dahej and Bileshwarpura (oral onco) received the U.S. FDA clearance, and it expects launch momentum to start from Q1 FY25
    Copy LinkShare onShare on Share on Share on
    Sharekhan decreased Buy price target of Torrent Pharmaceuticals Ltd. to 4024.0 on 29 Aug, 2025.
    logo
    Emcure Pharmaceuticals Ltd.
    03 Jul 2024
    1376.70
    1.06%
    Emcure Pharma IPO subscription status: Issue subscribed 75% so far on Day 1
    Business Standard
    Emcure Pharma IPO subscription status Day 1: Till 2:00 PM, Emcure Pharma IPO was subscribed 75 per cent, led by employees and non-institutional investors
    Copy LinkShare onShare on Share on Share on
    Emcure Pharmaceuticals Ltd. is trading below its 30 day SMA of 1416.0
    logo
    Dr. Reddy's Laboratories Ltd.
    03 Jul 2024
    US FDA Observation Acquisition
    1303.10
    -0.08%
    Dr Reddy's Reiterates Double-Digit Growth; Shares Hit Record
    Dr Reddy's Reiterates Double-Digit Growth; Shares Hit Record
    NDTV Profit
    Dr. Reddy's said it is on track to achieve consistent double-digit average revenue growth, 25% Ebitda, and a patient reach of over 1.5 billion.
    Copy LinkShare onShare on Share on Share on
    Dr. Reddy's Laboratories Ltd. is trading above all available SMAs
    logo
    Wockhardt Ltd.
    02 Jul 2024
    1527.30
    -2.09%
    Wockhardt enters last mile to bring two of its promising antibiotics to India
    Business Line
    Out-licencing talks for overseas markets, after global approvals, says Chairman
    Copy LinkShare onShare on Share on Share on
    Wockhardt Ltd. has an average target of 1870.00 from 1 broker.
    logo
    Pfizer Ltd.
    02 Jul 2024
    5167.50
    0.53%
    Pfizer, Moderna Covid vaccine patents battle to continue after UK ruling
    Business Standard
    Moderna had argued Pfizer and BioNTech copied mRNA advances it had pioneered and patented well before the Covid-19 pandemic began in late 2019
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 129 to 139 in Jun 2025 qtr.
    logo
    Marksans Pharma Ltd.
    02 Jul 2024
    174.20
    -1.53%
    Marksans Pharma Rises As UK Regulator Approves New Drugs
    Marksans Pharma Rises As UK Regulator Approves New Drugs
    NDTV Profit
    The company's subsidiary Relonchem, has received marketing authorisation for Rasagiline and Olmesartan drugs.
    Copy LinkShare onShare on Share on Share on
    Marksans Pharma Ltd. has lost -17.42% in the last 1 Month
    logo
    IOL Chemicals and Pharmaceuticals Ltd.
    02 Jul 2024
    110.89
    -2.35%
    IOLCP's stock rallies 10% after securing nod for cholesterol drug
    Business Standard
    The stock price jump came after the company got China's drug regulatory authority NMPA's nod for cholesterol drug Fenofibrate, allowing the company to export it to the Chinese market
    Copy LinkShare onShare on Share on Share on
    IOL Chemicals and Pharmaceuticals Ltd. average weekly volume is high.
    logo
    Ajanta Pharma Ltd.
    02 Jul 2024
    2572.00
    -0.84%
    Ajanta Pharma - Investments In Branded Generics Added Certainty, Scalability, Sustainability: Dolat Capital
    Ajanta Pharma - Investments In Branded Generics Added Certainty, Scalability, Sustainability: Dolat Capital
    NDTV Profit
    The company is focusing on increasing field force productivity, adding new products and geographies
    Copy LinkShare onShare on Share on Share on
    Ajanta Pharma Ltd. has an average target of 3022.00 from 5 brokers.
    logo
    J B Chemicals & Pharmaceuticals Ltd.
    01 Jul 2024
    Insider Trades
    1705.50
    -0.25%
    Kotak Equities initiates coverage on JB Chemicals with a target price of Rs 2,025
    Kotak Equities initiates coverage on JB Chemicals with a target price of Rs 2,025
    Economic Times
    Having primarily grown organically until FY2022 and later on aided by benefits from acquired brands, JB has handsomely outperformed the IPM in the past decade by ~600 bps and currently ranks 22 in the IPM, said Alankar Garude, Analyst at Kotak Equities.
    Copy LinkShare onShare on Share on Share on
    J B Chemicals & Pharmaceuticals Ltd. is trading below its 30 day SMA of 1720.4
    Stock Of The Day: JB Chemicals Surges After Kotak Initiates 'Buy'
    NDTV Profit | 01 Jul 2024
    logo
    Wockhardt Ltd.
    01 Jul 2024
    1527.30
    -2.09%
    Wockhardt stock soars over 19% after its investigational antibiotic Zaynich successfully treats cancer patient in US
    Business Line
    This marked the first instance in US, where Zaynich had been used to combat a complex infection caused by extreme-drug-resistant pseudomonas
    Copy LinkShare onShare on Share on Share on
    Wockhardt Ltd. has an average target of 1870.00 from 1 broker.
    more
    loading
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd